Show Summary Details

Quick Reference

A drug approved for treatment of chronic myeloid leukemia. The drug inhibits a tyrosine kinase enzyme p210 produced by the BCR‐ABL oncogene as a result of a translocation from chromosome ...

Subjects: Chemistry.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.